Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - NuOncology Labs Inc. (NLAB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Chart | Profile | Insider
Location
4870 Haygood Road, Suite 107
Virginia Beach, VA 23455
Phone: (757) 554-0926
Employees (last reported count): 7
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Services
 ·Industry: Business Services
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 84%
·Institutional: 0% (0% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
NuOncology Labs, Inc. is a development stage company engaged in the cancer research & clinical testing laboratories industries. In its pharmaceutical research NuOncology Labs engages in research, development, testing and licensing of promising pharmaceuticals and other cancer treatments. In its clinical laboratory business, the Company conducts predictive drug response tests for the optimization of chemotherapeutic cancer treatment of individual cancer patients and provides other contracted clinical testing services. Currently, the Company's subsidiaries, Paracure and IPRLL, have four issued patents and three additional allowed patent applications. Additionally, the subsidiaries have four U.S. and 12 international pending patent applications directed to various chemotherapy compounds and methods of cancer treatment.
More from Market Guide: Expanded Business Description

Financial Summary
NLAB is a development stage company engaged in the cancer research and clinical testing laboratories industries. It currently supports the research, development, testing, and licensing of cancer treatments and the delivery of predictive chemosensitivity tests for the optimization of contemporary cancer treatment. For the fiscal year ended 12/31/98, revenues totalled $34 thousand. Net loss totalled $597 thousand. Results are not comparable due to the company's 4/98 inception.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1998 Pay

Philip Enlow, 72
Chairman, CEO
$100K
Fraser Baker, Ph.D., 58
Sr. VP Clinical Testing & Research, Director
100K
Robert Thomas, 54
Sr. VP Bus. Devel., Director
100K
Dollar amounts are as of 31-Dec-1998 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NLABAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-May-2001
$0.02 
Recent Price$0.04 
52-Week High
on 1-Sep-2000
$0.45 
Beta3.50 
Daily Volume (3-month avg)16.0K
Daily Volume (10-day avg)20.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-88.2%
52-Week Change
relative to S&P500
-84.2%
Share-Related Items
Market Capitalization$754.0K
Shares Outstanding18.9M
Float3.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book ValueN/A 
Earnings (ttm)-$0.06 
EarningsN/A 
SalesN/A 
CashN/A 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDAN/A 
IncomeN/A 
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Dec-1998
Management Effectiveness
Return on AssetsN/A 
Return on EquityN/A 
Financial Strength
Current RatioN/A 
Debt/EquityN/A 
Total CashN/A 
Short Interest
Shares ShortN/A 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Dec-1998)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.